Evaluating External Counterpulsation ECP Therapy for Adults with Stable Angina Waiting for Coronary Bypass Surgery in Bandung, Indonesia
Led by Universitas Padjadjaran · Updated on 2023-09-25
84
Participants Needed
1
Research Sites
104 weeks
Total Duration
AI-Summary
What This Trial Is About
This research aims to evaluate the effectiveness of adding External Counterpulsation ECP therapy to standard medical treatment for patients with stable angina pectoris who are waiting for coronary artery bypass grafting CABG surgery. The study addresses the longer waiting times for CABG in Indonesia, which may increase risks during this period. The goal is to assess whether ECP can relieve symptoms and improve heart function and quality of life in these patients.
Participants will be randomly assigned to either the intervention group receiving ECP therapy or the control group receiving only medical treatment. ECP therapy involves 36 sessions, each lasting one hour, conducted five days a week with an initial pressure of 300mmHg. The control group will not receive this therapy. The study will compare changes in heart function and symptoms between the two groups.
Participants will undergo assessments before and after the seven-week intervention period, including echocardiography, treadmill tests, and questionnaires measuring angina severity and quality of life. Additional tests may include nuclear myocardial perfusion imaging and blood tests for heart-related biomarkers. Researchers will monitor major adverse cardiac events over two years and perform safety oversight. The total study duration includes the seven-week intervention and long-term follow-up for safety and effectiveness.
CONDITIONS
Brief Title
Effectiveness of ECP Therapy in Stable Angina Pectoris Patients
Research Team
M
Mohammad R Akbar, MD, FIHA.
B
Badai B Tiksnadi, MD, FIHA.
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match. Sign up to get personalized trial recommendations delivered to your inbox.
Indicated for CABG and on waiting list; or refused CABG and chose medical therapy; or assigned to medical treatment alone due to high CABG risk
Not planned for urgent CABG
On minimum optimal medical therapy for at least 2 weeks
Able and willing to sign informed consent and comply with study procedures
Lives in Bandung City or neighboring areas
Retired, not actively working during working hours, or willing to take time for study participation
You will not qualify if you...
Congestive Heart Failure
Chronic heart failure with NYHA Class III or IV
Left ventricular ejection fraction less than 35%
Unprotected left main stenosis greater than 50%
Blood pressure higher than 180/110 mmHg
Acute coronary syndrome
Acute heart failure
Severe aortic regurgitation
Malignant arrhythmia
Atrial fibrillation
Premature ventricular complex
Peripheral occlusive artery disease
Phlebitis
Deep vein thrombosis
Hemorrhagic diathesis
Severe chronic kidney disease
Aortic aneurysm
Abdominal aneurysm
Osteoarthritis
Low back pain
Pregnancy
Registered participant in another clinical study
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Implementation
Duration - Approximately 7 weeks
Participants in the intervention arm undergo External Counter Pulsation (ECP) therapy consisting of 36 sessions, each session lasting about 1 hour per day, five days a week. Participants in the control arm receive no intervention therapy.
36 sessions over 7 weeks (in-person)
Post-intervention Assessment
Duration - Short period immediately after intervention
Participants have assessments to evaluate changes in heart function, angina symptoms, quality of life, and other health markers before and after the intervention period.
2 visits (baseline and post-intervention assessments)
Long-term Monitoring
Duration - Up to 2 years
Participants are monitored for major adverse cardiac events (MACE) and overall health outcomes for up to 2 years following the intervention.
Periodic follow-up visits over 2 years
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
2
Similar Trials
COMPLEX Registry Study of Treatments and Outcomes in Adults with Complex and Calcified Coronary Artery Disease
Evaluating Artificial Intelligence Algorithms Using Blood Cell Data to Predict Acute Coronary Syndrome in Adults An Observational Study Comparing AI and Cardiac Troponin Testing
Evaluating External Counterpulsation ECP Therapy for Adults with Stable Angina Waiting for Coronary Bypass Surgery in Bandung, Indonesia
Study of Targeted Medicine Versus Placebo for Chest Pain with Non-Obstructive Coronary Arteries
Evaluating the Safety and Performance of the Freesolve Resorbable Magnesium Scaffold Compared to the Xience Drug-Eluting Stent in Treating Coronary Artery Lesions
SIROOP Registry A Study on Outcomes in Coronary Artery Disease Patients Treated with Sirolimus or Paclitaxel Coated Balloon Catheters
Have more questions? Get in touch with our team for quick support
Published Research Related To This Trial
Effect of Enhanced External Counter Pulsation Treatment on Aortic Blood Pressure, Arterial Stiffness and Ejection Fraction in Patients with Coronary Artery Disease.
Efficacy of Enhanced External Counterpulsation in Patients With Chronic Refractory Angina on Canadian Cardiovascular Society (CCS) Angina Class: An Updated Meta-Analysis.
Effectiveness of Enhanced External Counterpulsation Treatment on Symptom Burden, Medication Profile, Physical Capacity, Cardiac Anxiety, and Health-Related Quality of Life in Patients With Refractory Angina Pectoris.
The Effect of Enhanced External Counterpulsation Therapy and Improvement of Functional Capacity in Chronic Heart Failure patients: a Randomized Clinical Trial.
Starry H Rampengan, Joedo Prihartono, Minarma Siagian...